The authors emphasized that miR-21, in particular, may outperform miR-1 in predicting AHF in asymptomatic T2DM and that a biomarker panel combining miR-21 with NT-proBNP and Gal-3 provides enhanced predictive accuracy. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.